These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A comparative study of visual evoked potentials in optic neuritis and optic neuritis with multiple sclerosis. Samsen P; Chuenkongkaew WL; Masayaanon P; Chirapapaisan N; Ruangvaravate N; Loket S J Med Assoc Thai; 2007 Feb; 90(2):313-8. PubMed ID: 17375637 [TBL] [Abstract][Full Text] [Related]
5. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma. Parisi V; Miglior S; Manni G; Centofanti M; Bucci MG Ophthalmology; 2006 Feb; 113(2):216-28. PubMed ID: 16406535 [TBL] [Abstract][Full Text] [Related]
6. Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency. Niklas A; Sebraoui H; Hess E; Wagner A; Then Bergh F Mult Scler; 2009 Jan; 15(1):68-74. PubMed ID: 18701569 [TBL] [Abstract][Full Text] [Related]
7. Progression of visual evoked potential abnormalities in multiple sclerosis and optic neuritis. Alshuaib WB Electromyogr Clin Neurophysiol; 2000 Jun; 40(4):243-52. PubMed ID: 10907603 [TBL] [Abstract][Full Text] [Related]
8. Visual function correlates with nerve fiber layer thickness in eyes affected by ocular hypertension. Parisi V; Manni G; Gandolfi SA; Centofanti M; Colacino G; Bucci MG Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1828-33. PubMed ID: 10393056 [TBL] [Abstract][Full Text] [Related]
9. The temporal frequency response function of pattern ERG and VEP: changes in optic neuritis. Falsini B; Porciatti V Electroencephalogr Clin Neurophysiol; 1996 Sep; 100(5):428-35. PubMed ID: 8893660 [TBL] [Abstract][Full Text] [Related]
10. Bee sting optic neuritis. A case report with visual evoked potentials. Song HS; Wray SH J Clin Neuroophthalmol; 1991 Mar; 11(1):45-9. PubMed ID: 1827460 [TBL] [Abstract][Full Text] [Related]
11. VEP and PERG in patients with multiple sclerosis, with and without a history of optic neuritis. Janáky M; Jánossy Á; Horváth G; Benedek G; Braunitzer G Doc Ophthalmol; 2017 Jun; 134(3):185-193. PubMed ID: 28421377 [TBL] [Abstract][Full Text] [Related]
12. Is optical coherence tomography really a new biomarker candidate in multiple sclerosis?--A structural and functional evaluation. Gundogan FC; Demirkaya S; Sobaci G Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5773-81. PubMed ID: 18055831 [TBL] [Abstract][Full Text] [Related]
13. Retinal function and neural conduction along the visual pathways in affected and unaffected carriers with Leber's hereditary optic neuropathy. Ziccardi L; Sadun F; De Negri AM; Barboni P; Savini G; Borrelli E; La Morgia C; Carelli V; Parisi V Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6893-901. PubMed ID: 24071953 [TBL] [Abstract][Full Text] [Related]
14. Visual evoked potentials in multiple sclerosis patients treated with interferon beta-1a. Liscić RM; Brecelj J Croat Med J; 2004 Jun; 45(3):323-7. PubMed ID: 15185427 [TBL] [Abstract][Full Text] [Related]
15. Evolution of visual evoked potentials in optic neuritis. Heinrichs IH; McLean DR Can J Neurol Sci; 1988 Nov; 15(4):394-6. PubMed ID: 3208223 [TBL] [Abstract][Full Text] [Related]
16. The spatial tuning of steady state pattern electroretinogram in multiple sclerosis. Falsini B; Porrello G; Porciatti V; Fadda A; Salgarello T; Piccardi M Eur J Neurol; 1999 Mar; 6(2):151-62. PubMed ID: 10053227 [TBL] [Abstract][Full Text] [Related]